Status:
UNKNOWN
NEOZOL_Follow-up Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Locally Advanced Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Breast cancer is the most common cancer in women and is the leading cause of death from cancer in France. The main types of treatment used to treat breast cancer are surgery, chemotherapy, radiothera...
Eligibility Criteria
Inclusion
- Woman who signed a written consent, included and randomised in the main analysis of the NEOZOL study
Exclusion
- Patient's opposition to the use of her data in this study
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04899713
Start Date
May 1 2021
End Date
December 31 2021
Last Update
May 24 2021
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier de Bourg en Bresse, Hôpital Fleyriat, Service d'Onco-Hématologie et de Gynécologie Obstétrique
Bourg-en-Bresse, France, 01012
2
Hôpital Femme Mère Enfant, Groupement Hospitalier EST, Service de Gynécologie Clinique
Bron, France, 69677
3
Centre de Lutte Contre le Cancer - Institut Jean Perrin, Service de Médecine Oncologique
Clermont-Ferrand, France, 63011
4
Centre Hospitalier Alpes Léman, Service de Gynécologie
Contamine-sur-Arve, France, 74130